Glomerular filtration rate, albuminuria and risk of cardiovascular and all-cause mortality in type 2 diabetic individuals

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 4, 2011, Pages 294-301

  Targher, G ^a   Zoppini, G ^a   Chonchol, M ^b   Negri, C ^a   Stoico, V ^a   Perrone, F ^a   Muggeo, M ^a   Bonora, E ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Albuminuria; Chronic kidney disease; Epidemiology; Mortality; Type 2 diabetes

Indexed keywords

AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; ITALY; MALE; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PREVALENCE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ALBUMINURIA; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; ITALY; MALE; MIDDLE AGED; MORTALITY; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 79952701832     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.10.002     Document Type: Article

References (35)

1. Muntner P., He J., Hamm L., Loria C., Whelton P.K. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002, 13:745-753.
2. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
3. Manjunath G., Tighiouart H., Ibrahim H., MacLeod B., Salem D.N., Griffith J.L., et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003, 41:47-55.
4. Weiner D.E., Tighiouart H., Amin M.G., Stark P.C., MacLeod B., Griffith J.L., et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004, 15:1307-1315.
5. Rifkin D.E., Shlipak M.G., Katz R., Fried L.F., Siscovick D., Chonchol M., et al. Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 2008, 168:2212-2218.
6. van Domburg R.T., Hoeks S.E., Welten G.M., Chonchol M., Elhendy A., Poldermans D. Renal insufficiency and mortality in patients with known or suspected coronary artery disease. J Am Soc Nephrol 2008, 19:158-163.
7. Rossing P. Prediction, progression and prevention of diabetic nephropathy. The Minkowski lecture 2005. Diabetologia 2006, 49:11-19.
8. Nag S., Bilous R., Kelly W., Jones S., Roper N., Connolly V. All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years'data from the South Tees diabetes mortality study. Diabet Med 2007, 24:10-17.
9. Gerstein H.C., Mann J.F., Yi Q., Zinman B., Dinneen S.F., Hoogwerf B., et al. HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001, 286:421-426.
10. Hillege H.L., Fidler V., Diercks G.F., Van Glist W.H., de Zeeuw D., Van Veldhuisen D.J., et al. Prevention of Renal and Vascular End Stage Disease (PREVEND) study group. Urinary albumin excretion predicts cardiovascular and non-cardiovascular mortality in general population. Circulation 2002, 106:1777-1782.
11. de Zeeuw D. Renal disease: a common and a silent killer. Nat Clin Pract Cardiovasc Med 2008, 1(5 Suppl.):S27-S35.
12. Stiegler H., Standl E., Schulz K., Roth R., Lehmacher W. Morbidity, mortality, and albuminuria in type 2 diabetic patients: a three-year prospective study of a random cohort in general practice. Diabet Med 1992, 9:646-653.
13. Mattock M.B., Morrish N.J., Viberti G., Keen H., Fitzgerald A.P., Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992, 41:736-741.
14. Gall M.A., Borch-Johnsen K., Hougaard P., Nielsen F.S., Parving H.H. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995, 44:1303-1309.
15. Dinneen S.F., Gerstein H.C. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 1997, 157:1413-1418.
16. Stephenson J.M., Kenny S., Stevens L.K., Fuller J.H., Lee E. Proteinuria and mortality in diabetes: the WHO multinational study of vascular disease in diabetes. Diabet Med 1995, 12:149-155.
17. Valmadrid C.T., Klein R., Moss S.E., Klein B.E. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000, 160:1093-1100.
18. Bo S., Ciccone G., Gancia R., Rosato R., Grassi G., Merletti F., et al. Mortality within the first 10 years of the disease in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2006, 16:8-12.
19. Hallan S., Astor B., Romundstad S., Aasarod K., Kvenild K., Coresh J. Association of kidney function and albuminuria with cardiovascular mortality in older vs. younger individuals. The Hunt II study. Arch Intern Med 2007, 167:2490-2496.
20. So W.Y., Kong A.P., Ma R.C., Ozaki R., Szeto C.C., Chan N.N., et al. Glomerular filtration rate, cardiorenal endpoints, and all-cause mortality in type 2 diabetic patients. Diabetes Care 2006, 29:2046-2052.
21. Bruno G., Merletti F., Bargero G., Novelli G., Melis D., Soddu A., et al. Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study. Diabetologia 2007, 50:941-948.
22. DAI Study Group The prevalence of coronary heart disease in type 2 diabetic patients in Italy: the DAI study. Diabet Med 2004, 21:738-745.
23. Comaschi M., Coscelli C., Cucinotta D., Malini P., Manzato E., Nicolucci A. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study. Nutr Metab Cardiovasc Dis 2005, 15:204-211. SFIDA Study Group -Italian Association of Diabetologists (AMD).
24. Avogaro A., Guida P., Giorda C., Mannucci E., Medea G., Comaschi M., et al. The under-use of statin in type 2 diabetic patients attending diabetic clinics in Italy. Nutr Metab Cardiovasc Dis 2007, 17:32-40.
25. Targher G., Bertolini L., Padovani R., Rodella S., Tessari R., Zenari L., et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007, 30:1212-1218.
26. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002, 39(Suppl. 1):S1-S266.
27. American Diabetes Association Standards of medical care in diabetes-2009. Diabetes Care 2009, 31(Suppl. 1):S13-S61.
28. World Health Organization International classification of diseases, ninth revision, clinical modification (ICD-9-CM) 1991, Health Care Financing Administration, Public Health Service, US Department of Health and Human Services, Washington, DC.
29. Hsu C.Y., Go A.S., McCulloch C.E., Darbinian J., Iribarren C. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease. Clin J Am Soc Nephrol 2007, 2:81-88.
30. Coresh J., Selvin E., Stevens L.A., Manzi J., Kusek J.W., Eggers P., et al. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298:2038-2047.
31. Irie F., Iso H., Sairenchi T., Fukasawa N., Yamagishi K., Ikehara S., et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int 2006, 69:1264-1271.
32. Astor B.C., Hallan S.I., Miller E.R., Yeung E., Coresh J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol 2008, 167:1226-1234.
33. Schiffrin E.L., Lipman M.L., Mann J.F.E. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007, 116:85-97.
34. Stevens L.A., Coresh J., Greene T., Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006, 354:2473-2483.
35. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., et al. American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003, 108:2154-2169.